Your browser doesn't support javascript.
Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines: A Historical Viral Vaccine Perspective.
Sayers, David R.
  • Sayers DR; Department of the Air Force, AFMRA/SG3PM, Falls Church, VA 22042, USA.
Mil Med ; 187(9-10): 233-234, 2022 08 25.
Article in English | MEDLINE | ID: covidwho-1769320
ABSTRACT
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines are a remarkable scientific achievement. The perspective on past viral vaccine performance and viral characteristics, such as incubation period, can help with messaging and instilling vaccine confidence. Protection against mild infection occurs in the short term (months), but the persistence of protection against severe disease will likely endure longer.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Viral Vaccines / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Mil Med Year: 2022 Document Type: Article Affiliation country: Milmed

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Viral Vaccines / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Mil Med Year: 2022 Document Type: Article Affiliation country: Milmed